Literature DB >> 2118996

Wild-type V(D)J recombination in scid pre-B cells.

E A Hendrickson1, M S Schlissel, D T Weaver.   

Abstract

Homozygous mutation at the scid locus in the mouse results in the aberrant rearrangement of immunoglobulin and T-cell receptor gene segments. We introduced a retroviral vector containing an inversional immunoglobulin rearrangement cassette into scid pre-B cells. Most rearrangements were accompanied by large deletions, consistent with previously characterized effects of the scid mutation. However, two cell clones were identified which contained perfect reciprocal fragments and wild-type coding joints, documenting, on a molecular level, the ability of scid pre-B cells to generate functional protein-coding domains. Subsequent rearrangement of the DGR cassette in one of these clones was accompanied by a deletion, suggesting that this cell clone had not reverted the scid mutation. Indeed, induced rearrangement of the endogenous kappa loci in these two cell clones resulted in a mixture of scid and wild-type V-J kappa joints, as assayed by a polymerase chain reaction and DNA sequencing. In addition, three immunoglobulin mu- scid pre-B cell lines showed both scid and wild-type V-J kappa joins. These experiments strongly suggest that the V(D)J recombinase activity in scid lymphoid cells is diminished but not absent, consistent with the known leakiness of the scid mutation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118996      PMCID: PMC361240          DOI: 10.1128/mcb.10.10.5397-5407.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  30 in total

1.  DNA elements are asymmetrically joined during the site-specific recombination of kappa immunoglobulin genes.

Authors:  S Lewis; A Gifford; D Baltimore
Journal:  Science       Date:  1985-05-10       Impact factor: 47.728

2.  Inducible transcription of the unrearranged kappa constant region locus is a common feature of pre-B cells and does not require DNA or protein synthesis.

Authors:  K J Nelson; D E Kelley; R P Perry
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

Review 3.  The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition.

Authors:  M Kronenberg; G Siu; L E Hood; N Shastri
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

4.  Joining of immunoglobulin heavy chain gene segments: implications from a chromosome with evidence of three D-JH fusions.

Authors:  F W Alt; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

5.  Joining of V kappa to J kappa gene segments in a retroviral vector introduced into lymphoid cells.

Authors:  S Lewis; A Gifford; D Baltimore
Journal:  Nature       Date:  1984 Mar 29-Apr 4       Impact factor: 49.962

Review 6.  Somatic generation of antibody diversity.

Authors:  S Tonegawa
Journal:  Nature       Date:  1983-04-14       Impact factor: 49.962

7.  A severe combined immunodeficiency mutation in the mouse.

Authors:  G C Bosma; R P Custer; M J Bosma
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

8.  Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease.

Authors:  K Dorshkind; G M Keller; R A Phillips; R G Miller; G C Bosma; M O'Toole; M J Bosma
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Normal recombination substrate VH to DJH rearrangements in pre-B cell lines from scid mice.

Authors:  P Ferrier; L R Covey; S C Li; H Suh; B A Malynn; T K Blackwell; M A Morrow; F W Alt
Journal:  J Exp Med       Date:  1990-06-01       Impact factor: 14.307

View more
  21 in total

1.  Ku70-deficient embryonic stem cells have increased ionizing radiosensitivity, defective DNA end-binding activity, and inability to support V(D)J recombination.

Authors:  Y Gu; S Jin; Y Gao; D T Weaver; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 2.  SCID mice in the study of human autoimmune diseases.

Authors:  M A Duchosal
Journal:  Springer Semin Immunopathol       Date:  1992

3.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-06-25       Impact factor: 16.971

4.  Strand breaks without DNA rearrangement in V (D)J recombination.

Authors:  E A Hendrickson; V F Liu; D T Weaver
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

5.  Efficient nonhomologous and homologous recombination in scid cells.

Authors:  B Bühler; G Köhler; P J Nielsen
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  Biochemical and genetic defects in the DNA-dependent protein kinase in murine scid lymphocytes.

Authors:  J S Danska; D P Holland; S Mariathasan; K M Williams; C J Guidos
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

7.  Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease model.

Authors:  S J Pirruccello; H Nakamine; K W Beisel; K L Kleveland; M Okano; Y Taguchi; J R Davis; M L Mahloch; D T Purtilo
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

8.  V(D)J recombination coding junction formation without DNA homology: processing of coding termini.

Authors:  N V Boubnov; Z P Wills; D T Weaver
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

Review 9.  The polymerase chain reaction in diagnosing lymphoid disorders.

Authors:  K P McCarthy; D N Slack; J P Sloane
Journal:  Mol Biol Rep       Date:  1994-01       Impact factor: 2.316

10.  Analysis of the defect in DNA end joining in the murine scid mutation.

Authors:  J Harrington; C L Hsieh; J Gerton; G Bosma; M R Lieber
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.